Inducing Tumor Cell Death by RIG-I: The Future of Breast Cancer?

By Riya Gandhi ‘22 In recent years cancer therapy – especially cancer immunotherapy – has gained momentum and scientists’ interest has turned to immune checkpoint inhibitors (ICIs). ICIs aid in the suppression of checkpoint receptors to produce powerful immune responses against tumors. Although such a procedure is gaining momentum in clinical settings, much research must…

Investigating the Link Between Cancer Cells and Embryonic Cells to Treat Cancer

By Snigdha Kanadibhotla ‘21 Fundamentally rooted in a lack of cell cycle control, cancer is predicted to affect 38.4% of Americans within their lifetimes (1). While most healthy cells are regulated by three cell cycle checkpoints, cancerous cells can bypass these regulatory systems, which leads to uncontrolled division and metastasis (the spread of cancer through…